by Eric Christianson | Feb 15, 2023 | Personal Stories From The Front Lines of Clinical Pharmacy
This article was originally written by Christine Meyer, MD and I found this story too good not to share. I’m appreciative to her for letting me share it. Deprescribing and dose reductions require all hands on deck. Kudos to all of you pharmacists out there doing...
by Eric Christianson | Jan 1, 2023 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
Opioids are commonly used in clinical practice. Selection on these agents can often be confusion. We’ve outlined some of the most important pharmacokinetic, pharmacogenomic, and dosage form clinical pearls in the table below. For easier reading, we have also...
by Eric Christianson | Dec 21, 2022 | Clinical Guideline Updates For Pharmacists
As the concerns surrounding opioid use have evolved, there have been more guidelines and organizations recommending guidance on prescribing practices of opioids. Today, we’ll be breaking down what you need to know from the 2022 CDC Opioid Guidelines’ recent...
by Eric Christianson | Aug 24, 2022 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
I frequently work with patients and caregivers who are managing patients at the end of life and in hospice-type situations. Knowing and understanding differences between common opioids is critical to my work as a clinical pharmacist. In this article, I’ll...
by Eric Christianson | Aug 7, 2019 | Educational Case Studies For Pharmacists, Polypharmacy Cases And The Prescribing Cascade
In this polypharmacy case study, I pick out some medications that we may be able to discontinue. An 88-year-old male is looking to reduce his medication burden. Current medications include: Aspirin 81 mg dailyFurosemide 10 mg dailyKCL 10 meq dailyOmeprazole 20 mg...
